News Daily News FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention Shelley Wood June 01, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020